Intervacc Financial Statements From 2010 to 2024
| IVACC Stock | SEK 2.44 0.10 3.94% |
Check Intervacc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intervacc's main balance sheet or income statement drivers, such as , as well as many indicators such as . Intervacc financial statements analysis is a perfect complement when working with Intervacc Valuation or Volatility modules.
Intervacc |
Intervacc AB Company Operating Margin Analysis
Intervacc's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Intervacc Operating Margin | (4.77) % |
Most of Intervacc's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intervacc AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Intervacc AB has an Operating Margin of -4.7749%. This is 86.39% lower than that of the Healthcare sector and 95.74% lower than that of the Biotechnology industry. The operating margin for all Sweden stocks is 13.34% lower than that of the firm.
Intervacc AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intervacc's current stock value. Our valuation model uses many indicators to compare Intervacc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intervacc competition to find correlations between indicators driving Intervacc's intrinsic value. More Info.Intervacc AB is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intervacc's earnings, one of the primary drivers of an investment's value.About Intervacc Financial Statements
Intervacc shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Intervacc investors may analyze each financial statement separately, they are all interrelated. The changes in Intervacc's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intervacc's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Intervacc AB , a biotechnology company, engages in the research and development of veterinary vaccines using recombinant proteins for animal health. The company has a collaboration with the Karolinska Institute. Intervacc operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intervacc Stock Analysis
When running Intervacc's price analysis, check to measure Intervacc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intervacc is operating at the current time. Most of Intervacc's value examination focuses on studying past and present price action to predict the probability of Intervacc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intervacc's price. Additionally, you may evaluate how the addition of Intervacc to your portfolios can decrease your overall portfolio volatility.